Please use this identifier to cite or link to this item:
PIRA download icon_1.1View/Download Full Text
Title: Iron-chelating drugs enhance cone photoreceptor survival in a mouse model of retinitis pigmentosa
Authors: Wang, K
Peng, B
Xiao, J
Weinreb, O
Youdim, MBH
Lin, B 
Issue Date: 2017
Source: Investigative ophthalmology and visual science, 2017, v. 58, no. 12, p. 5287-5297
Abstract: PURPOSE. Retinitis pigmentosa (RP) is a group of hereditary retinal degeneration in which mutations commonly result in the initial phase of rod cell death followed by gradual cone cell death. The mechanisms by which the mutations lead to photoreceptor cell death in RP have not been clearly elucidated. There is currently no effective treatment for RP. The purpose of this work was to explore iron chelation therapy for improving cone survival and function in the rd10 mouse model of RP. METHODS. Two iron-chelating drugs, 5-(4-(2-hydroxyethyl) piperazin-1-yl (methyl)-8-hydroxyquinoline (VK28) and its chimeric derivative 5-(N-methyl-N-propargyaminomethyl)-quinoline- 8-oldihydrochloride (VAR10303), were injected intraperitoneally to rd10 mice every other day starting from postnatal day 14. We investigate the effects of the two compounds on cone rescue at three time points, using a combination of immunocytochemistry, RT-PCR, Western blot analysis, and a series of visual function tests. RESULTS. VK28 and VAR10303 treatments partially rescued cones, and significantly improved visual function in rd10 mice. Moreover, we showed that the neuroprotective effects of VK28 and VAR10303 were correlated to inhibition of neuroinflammation, oxidative stress, and apoptosis. Furthermore, we demonstrated that downregulation of NF-kB and p53 is likely to be the mechanisms by which proinflammatory mediators and apoptosis are reduced in the rd10 retina, respectively. CONCLUSIONS. VK28 and VAR10303 provided partial histologic and functional rescue of cones in RD10 mice. Our study demonstrated that iron chelation therapy might represent an effective therapeutic strategy for RP patients.
Keywords: Iron-chelating drugs
Rd10 mice
Vision rescue
Publisher: Association for Research in Vision and Ophthalmology
Journal: Investigative ophthalmology and visual science 
ISSN: 0146-0404
EISSN: 1552-5783
DOI: 10.1167/iovs.17-22096
Rights: Copyright 2017 The Authors
This work is licensed under a Creative Commons Attribution-NonCommercial-NonDerivatives 4.0 International License.
Appears in Collections:Journal/Magazine Article

Files in This Item:
File Description SizeFormat 
i1552-5783-58-12-5287.pdf1.66 MBAdobe PDFView/Open
Open Access Information
Status open access
File Version Version of Record
View full-text via PolyU eLinks SFX Query
Show full item record

Page views

Last Week
Last month
Citations as of Jun 4, 2023


Citations as of Jun 4, 2023


Last Week
Last month
Citations as of Jun 2, 2023


Last Week
Last month
Citations as of Jun 1, 2023

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.